| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:NT376 CAS:2820208-97-5 Package:50mg;10mg
|
|
| | Benzamide, 2-fluoro-N-[(1R)-1-methyl-2-[methyl(phenylmethyl)amino]ethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]- Basic information |
| | Benzamide, 2-fluoro-N-[(1R)-1-methyl-2-[methyl(phenylmethyl)amino]ethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]- Chemical Properties |
| density | 1.297±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 12.89±0.46(predicted) |
| | Benzamide, 2-fluoro-N-[(1R)-1-methyl-2-[methyl(phenylmethyl)amino]ethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]- Usage And Synthesis |
| Uses | NT376 is a high potency and selectivity inhibitor of class-IIa Histone deacetylases (HDAC) with an IC50 value of 32 nM, similar to NT160 (HY-149285) (IC50= 46 nM) in HT-29 cells. NT376 is proming for research of various cancers and in the diseases of the central nervous system (CNS) such as Alzheimer’s and Huntington’s diseases[1]. | | IC 50 | HDAC4: 1.26 nM (IC50, HT-29 cells); HDAC5: 2.85 nM (IC50, HT-29 cells); HDAC1: 1483 nM (IC50, HT-29 cells); HDAC11: 4851 nM (IC50, HT-29 cells); Class I/IIb: >4000 nM (IC50, HT-29 cells); HDAC6: 5035 nM (IC50, HT-29 cells) | | References | [1] Xu S, et al. Design and radiosynthesis of class-IIa HDAC inhibitor with high molar activity via repositioning the 18F-radiolabel[J]. Sci Rep. 2024 Jul 2;14(1):15100. DOI:10.1038/s41598-024-65668-z |
| | Benzamide, 2-fluoro-N-[(1R)-1-methyl-2-[methyl(phenylmethyl)amino]ethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]- Preparation Products And Raw materials |
|